Abstracts - faqs.org

Abstracts

Business, general

Search abstracts:
Abstracts » Business, general

OGE Energy Corp

Article Abstract:

Earnings of OGE Earning Corp. may decline slightly owing to rate reduction and an order to build or buy additional 400 megatwatts capacity issued by the Oklahoma Corporation Commission. Stocks are not recommended at this time.

Author: Debbas, Paul E.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2003
Legal issues & crime, Government regulation (cont), Government regulation, Legal/Government Regulation, Laws, regulations and rules, OGE Energy Corp., OGE, Oklahoma. Oklahoma Corporation Commission

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Great Plains Energy Inc

Article Abstract:

Great Plains Energy Inc. may post an earnings decline this year but this is expected to improve in 2004. Cash flow will improve and dividends may remain at the current level.

Author: Debbas, Paul E.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2003
Great Plains Energy Inc.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: United States, Evaluation, Electric utilities, Finance, Company investment, Investments, Statistics, Company sales and earnings, Company earnings/profit, Rankings, Company business forecast/projection, Company forecasts
Similar abstracts:
  • Abstracts: Energen Corp. Energen Corporation
  • Abstracts: Massey Energy Co.. Ecolab Inc.. Crompton Corp
  • Abstracts: Massey Energy Company. Phelps Dodge
  • Abstracts: Ameren. Level 3 Communications Inc
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.